A Masked, Randomized, Phase 3 Comparison of Triple Fixed-Combination Bimatoprost/Brimonidine/Timolol versus Fixed-Combination Brimonidine/Timolol for Lowering Intraocular Pressure

OBJECTIVE: To evaluate the efficacy and safety of triple fixed-combination bimatoprost 0.01%/brimonidine 0.15%/timolol 0.5% (TFC) versus dual fixed-combination brimonidine 0.2%/timolol 0.5% (DFC) in primary open-angle glaucoma and ocular hypertension. METHODS: Patients with intraocular pressure (IOP...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Ophthalmol
Auteurs principaux: Hartleben, Curt, Parra, Juan Camilo, Batoosingh, Amy, Bernstein, Paula, Goodkin, Margot
Format: Artigo
Langue:Inglês
Publié: Hindawi 2017
Sujets:
Clinical Study
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5625812/
https://ncbi.nlm.nih.gov/pubmed/29057117
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/4586763
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires